Myeloproliferative Syndrome

Publisher Website
Google Scholar
Abstract
Introduction Several authors 2-4,12 have theorized that a whole host of clinical entities, grouped under the title of "myeloproliferative syndrome," have a common pathogenesis and perhaps a common etiology. The clinical entities usually included under the title of "myeloproliferative syndrome" are myelofibrosis with myeloid metaplasia, polycythemia vera, chronic myelogenous leukemia, primary thrombocythemia, and the di Guglielmo syndromes. Some authors have speculated that certain lymphomas should also be included.3 The evidence presented in favor of a unitary view of this group of illnesses usually consists of (1) the common ancestry, in the primitive multipotential mesenchymal cell, of the cell lines involved in the clinical entities listed; (2) the frequent observation of intermediate forms, that is, features characteristic for several of the clinical entities seen in the same patient; (3) the natural evolution of any one of these entities into one another. It is with respect to the last point that

This publication has 0 references indexed in Scilit: